Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-16-016350
Filing Date
2016-03-21
Accepted
2016-03-21 19:41:16
Documents
1
Period of Report
2016-03-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3920
  Complete submission text file 0000899243-16-016350.txt   5500
Mailing Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738
Business Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738 512-519-0400
VERMILLION, INC. (Issuer) CIK: 0000926617 (see all company filings)

EIN.: 330595156 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 63 INDIAN LEDGE RD. MONROE CT 06468
Business Address
Palmieri Valerie Barber (Reporting) CIK: 0001623017 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34810 | Film No.: 161519736